- Home
- RDZN vs AVTE Comparison
RDZN vs AVTE Comparison
Compare RDZN & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- AVTE
- Stock Information
- Founded
- RDZN 2015
- AVTE 2018
- Country
- RDZN United States
- AVTE United States
- Employees
- RDZN N/A
- AVTE N/A
- Industry
- RDZN Blank Checks
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- RDZN Finance
- AVTE Health Care
- Exchange
- RDZN Nasdaq
- AVTE Nasdaq
- Market Cap
- RDZN 86.1M
- AVTE 72.5M
- IPO Year
- RDZN N/A
- AVTE 2021
- Fundamental
- Price
- RDZN $1.26
- AVTE $2.52
- Analyst Decision
- RDZN Strong Buy
- AVTE Hold
- Analyst Count
- RDZN 2
- AVTE 7
- Target Price
- RDZN $5.00
- AVTE $11.75
- AVG Volume (30 Days)
- RDZN 161.7K
- AVTE 61.1K
- Earning Date
- RDZN 02-12-2025
- AVTE 03-27-2025
- Dividend Yield
- RDZN N/A
- AVTE N/A
- EPS Growth
- RDZN N/A
- AVTE N/A
- EPS
- RDZN N/A
- AVTE N/A
- Revenue
- RDZN $42,893,256.00
- AVTE N/A
- Revenue This Year
- RDZN $4.52
- AVTE N/A
- Revenue Next Year
- RDZN $53.72
- AVTE N/A
- P/E Ratio
- RDZN N/A
- AVTE N/A
- Revenue Growth
- RDZN 2.79
- AVTE N/A
- 52 Week Low
- RDZN $0.71
- AVTE $1.25
- 52 Week High
- RDZN $6.67
- AVTE $30.29
- Technical
- Relative Strength Index (RSI)
- RDZN 57.45
- AVTE 53.59
- Support Level
- RDZN $0.96
- AVTE $2.45
- Resistance Level
- RDZN $1.11
- AVTE $2.56
- Average True Range (ATR)
- RDZN 0.13
- AVTE 0.08
- MACD
- RDZN 0.03
- AVTE 0.00
- Stochastic Oscillator
- RDZN 73.86
- AVTE 80.00
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.